DistilNFO HospitalIT
DistilNFO HospitalIT Advisory

Weekly Top Stories

Mon, 01 Apr 2019
1. Sutter Health Launches Epic EHR-Integrated Virtual Assistant
2. Dignity Health brings specialty pharmacy in-house
3. FDA regulations could create digital health opportunities for pharma
4. Novartis to price new MS drug at $88K per year: 5 notes
5. KY Hospital Expands Partnership with Allscripts EHR, Patient Portal
6. UM health spinoff Fifth Eye nabs $11 million VC round
7. Moberg Pharma Completes the Divestment of the OTC-business for USD 155 million
8. Health IT consulting firms trying to get closer to health systems
9. Mount Sinai and German IT institute collaborate on digital health
10. Bristol-Myers Squibb, Concerto HealthAI partner on real-world data clinical research
Sutter Health will launch an Epic EHR-integrated virtual assistant powered by artificial intelligence to streamline clinical care. Healthcare providers at Sutter Health’s Northern California campus will soon have access to an Epic...
Share: email linkedin twitter facebook
San Francisco-based Dignity Health opened its hospital-owned specialty pharmacy March 26. The specialty pharmacy, built in partnership with specialty pharmacy integrator Shields Health Solutions, aims to improve health outcomes of patients ...
Share: email linkedin twitter facebook
A new report from PwC predicts that new and proposed FDA regulations could open up doors for pharmaceutical companies looking to develop digital tools. Within the last few years the FDA has undergone a metamorphosis when it comes to digital...
Share: email linkedin twitter facebook
Novartis won approval for its multiple sclerosis drug Mayzent, which will launch at a price of $88,000 annually, according to Reuters. Five notes: 1. Mayzent, an oral drug, was approved for adults with relapsing forms of MS. 2. ...
Share: email linkedin twitter facebook
Ephraim McDowell Health has partnered with Allscripts EHR to improve patient engagement and care quality. Kentucky-based Ephraim McDowell Health has expanded its partnership with Allscripts EHR as part of an effort to boost its ability to...
Share: email linkedin twitter facebook
Fifth Eye Inc., a health care spinoff from the University of Michigan, will announce Monday that it has closed on a Series A venture-capital round of $11.5 million. The funding was led by two new investors, Ann Arbor-based Arboretum Venture...
Share: email linkedin twitter facebook
Moberg Pharma AB has today completed the divestment of its OTC-business to RoundTable Healthcare Partners and Signet Healthcare Partners for USD 155 million. After the divestment, Moberg Pharma’s remaining business consists of the...
Share: email linkedin twitter facebook
While demand for implementing electronic health record systems within hospitals and health systems remains consistent, health IT consulting firms are discovering new challenges as some providers revisit their current systems for the first...
Share: email linkedin twitter facebook
Mount Sinai Health System and the Hasso Plattner Institute have teamed up to launch a digital health institute, which will focus on developing products with predictive and preventive capabilities that improve health outcomes. New York-based...
Share: email linkedin twitter facebook
The pharma company will gain access to Concerto Health’s eurekaHealth, an AI and machine learning platform. Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal...
Share: email linkedin twitter facebook


Health Plan Hospital IT
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.

Contact Us

5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311

© DistilNFO Publications

DistilNFO is media company that publishes Industry news, views and Interviews. Our IT Directories help solution providers connect with clients. We distil the information for you – saving time and keeping you up to date on your interest areas.


You are receiving this newsletter because you are subscribed to one or more DistilNFO Publications Newsletter/s. We do not share your e-mail address to anyone without your consent. If you feel this email was sent by mistake, you can unsubscribe or update your subscription using the link below.

View in browser | Update Subscription | Advertise | Contact Us